Tunn U W, Thieme H
Arch Intern Med. 1982 Oct 25;142(11):2035-8.
Urosepsis is mostly induced by nosocomial gram-negative organisms. It is an infection that is difficult to treat and has high mortality, especially when associated with septic shock. For obstructive urosepsis, which occurs mostly after an acute stone occlusion of the upper urinary tract in pyelonephritis, intensive systemic medical therapy and drainage (and sometimes removal) of the septic kidney are necessary. For non-obstructive urosepsis, which is mostly an iatrogenic complication of diagnostic or therapeutic procedures on the genito-urinary tract, the same intensive medical care and urinary drainage are adequate. Systemic therapy in the treatment of urosepsis encompasses several disorders. Specific pathogenic mechanisms of shock, including failure of the microcirculation, hemostatic disorders, and microbiological problems, have to be considered in the systemic treatment of urosepsis. Appropriate antibiotic therapy may triple chances of survival. In this connection, piperacillin was successfully used in 30 patients with urosepsis treated at our institution.
泌尿道感染性败血症大多由医院内革兰氏阴性菌引起。它是一种难以治疗且死亡率高的感染,尤其是在合并感染性休克时。对于梗阻性泌尿道感染性败血症,其大多发生在肾盂肾炎中急性上尿路结石梗阻之后,强化的全身药物治疗以及对感染性肾脏进行引流(有时需切除)是必要的。对于非梗阻性泌尿道感染性败血症,其大多是泌尿生殖道诊断或治疗操作的医源性并发症,同样的强化医疗护理和尿液引流就足够了。泌尿道感染性败血症治疗中的全身治疗涉及多种病症。在泌尿道感染性败血症的全身治疗中,必须考虑休克的特定致病机制,包括微循环衰竭、止血障碍和微生物学问题。适当的抗生素治疗可使存活几率增加两倍。就此而言,哌拉西林在我们机构治疗的30例泌尿道感染性败血症患者中成功使用。